Drug Approval | October 21, 2024
Alembic receives USFDA final approval for Diltiazem Hydrochloride ER capsules
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Granules now has a total of 67 ANDA approvals from the USFDA
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
Lamotrigine extended-release tablets are indicated for adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The product is expected to be launched in Q3FY25
Potential of Ayurveda’s contribution in global health system through various innovative practices
Bumetanide Injection USP (RLD Bumex) had estimated annual sales of USD 20 million in the U.S.
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Subscribe To Our Newsletter & Stay Updated
